Search in:

Scandinavian Journal of Clinical and Laboratory Investigation Volume 78, 2018 - Issue 7-8

Submit an article Journal homepage

Open access

2,935

Views

CrossRef citations to date

Altmetric

Articles

Effects of the oral, direct factor Xa inhibitor edoxaban on routine coagulation assays, lupus anticoagulant and anti-Xa assays

Andreas HillarpDepartment of Clinical Chemistry and Transfusion Medicine, Halland County Hospital, Halmstad, Sweden;

Karin StrandbergDepartment of Clinical Chemistry, University and Regional Laboratories Region Skåne, Malmö, Sweden;

Fariba BaghaeiDepartment of Medicine, Coagulation Centre, Sahlgrenska University Hospital, Gothenburg, Sweden;

Inger Fagerberg BlixterDepartment of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden;

Kerstin M. GustafssonDepartment of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden

Tomas L. LindahlDepartment of Clinical and Experimental Medicine, Linköping University, Linköping, SwedenCorrespondence[email protected]

http://orcid.org/0000-0003-0174-8152

Pages 575-583 | Received 20 May 2018, Accepted 09 Sep 2018, Published online: 02 Oct 2018

Cite this article
https://doi.org/10.1080/00365513.2018.1522664
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (13)

Oliver Grottke, Arash Afshari, Aamer Ahmed, Eleni Arnaoutoglou, Daniel Bolliger, Christian Fenger-Eriksen & Christian von Heymann. (2024) Clinical guideline on reversal of direct oral anticoagulants in patients with life threatening bleeding. European Journal of Anaesthesiology 41:5, pages 327-350.
Crossref

Gabor Erdoes, Aamer Ahmed, Stephan D. Kurz, Daniel Gerber & Daniel Bolliger. (2023) Perioperative hemostatic management of patients with type A aortic dissection. Frontiers in Cardiovascular Medicine 10.
Crossref

Gary W. Moore. (2023) Analytical dilemmas in lupus anticoagulant detection. Exploration of Immunology, pages 300-324.
Crossref

Ulrich J. Sachs. (2023) Pitfalls in Coagulation Testing. Hämostaseologie 43:01, pages 060-066.
Crossref

Sha Xiao, Yuancai Luo, Lu Guo, Jing Zhang, Liping Mu & Zhao Ye. (2023) Comparison of doses of heparin for venous thromboembolism and bleeding in pregnant women. Journal of Investigative Medicine 70:3, pages 773-779.
Crossref

Romain Siriez, Halil Yildiz, Céline Bouvy, Hélène Haguet, Vincent Maloteau, Michaël Hardy, François Mullier, Jean‐Michel Dogné, Philippe Hainaut & Jonathan Douxfils. (2022) The edoxaban‐M4 metabolite and measurement of edoxaban by chromogenic assays in human plasma. Research and Practice in Thrombosis and Haemostasis 6:3, pages e12680.
Crossref

Romain Siriez, Jean‐Michel Dogné, Robert Gosselin, Julie Laloy, François Mullier & Jonathan Douxfils. (2020) Comprehensive review of the impact of direct oral anticoagulants on thrombophilia diagnostic tests: Practical recommendations for the laboratory. International Journal of Laboratory Hematology 43:1, pages 7-20.
Crossref

Rohi Shah, Nomaan Sheikh, Jitendra Mangwani, Nicolette Morgan & Hamidreza Khairandish. (2021) Direct oral anticoagulants (DOACs) and neck of femur fractures: Standardising the perioperative management and time to surgery. Journal of Clinical Orthopaedics and Trauma 12:1, pages 138-147.
Crossref

Grzegorz Grześk, Anita Woźniak-Wiśniewska, Jan Błażejewski, Bartosz Górny, Łukasz Wołowiec, Daniel Rogowicz & Alicja Nowaczyk. (2020) The Interactions of Nintedanib and Oral Anticoagulants—Molecular Mechanisms and Clinical Implications. International Journal of Molecular Sciences 22:1, pages 282.
Crossref

Gustavo Guimarães Moreira Balbi, Marcelo de Souza Pacheco, Odirlei Andre Monticielo, Andreas Funke, Adriana Danowski, Mittermayer Barreto Santiago, Henrique Luiz Staub, Jozelia Rêgo & Danieli Castro Oliveira de Andrade. (2020) Antiphospholipid Syndrome Committee of the Brazilian Society of Rheumatology position statement on the use of direct oral anticoagulants (DOACs) in antiphospholipid syndrome (APS). Advances in Rheumatology 60:1.
Crossref

Andreas Hillarp, Karin Strandberg, Kerstin M. Gustafsson & Tomas L. Lindahl. (2020) Unveiling the complex effects of direct oral anticoagulants on dilute Russell's viper venom time assays. Journal of Thrombosis and Haemostasis 18:8, pages 1866-1873.
Crossref

Sara Reda, Anna Brügelmann, Jens Müller, Johannes Oldenburg, Bernd Pötzsch & Heiko Rühl. (2020) Functional lupus anticoagulant testing in a large retrospective cohort of thrombosis patients with direct oral anticoagulants. Scientific Reports 10:1.
Crossref

Sophie Testa, Claudia Dellanoce, Oriana Paoletti, E. Cancellieri, Rossella Morandini, Maurizio Tala, Silvia Zambelli & Cristina Legnani. (2019) Edoxaban plasma levels in patients with non-valvular atrial fibrillation: Inter and intra-individual variability, correlation with coagulation screening test and renal function. Thrombosis Research 175, pages 61-67.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Effects of the oral, direct factor Xa inhibitor edoxaban on routine coagulation assays, lupus anticoagulant and anti-Xa assays

Articles from other publishers (13)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Effects of the oral, direct factor Xa inhibitor edoxaban on routine coagulation assays, lupus anticoagulant and anti-Xa assays

Citations (13)

Articles from other publishers (13)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date